Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

[1] Todo S(1991)Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 619-626

[2] Demetris AJ(1991)Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 150-157

[3] Van Thiel D(1992)Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications J Hepatol 14 104-111

[4] Teperman L(2001)A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation Liver Transplant 7 504-510

[5] Fung JJ(1997)Hepatitis-B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation Lancet 349 20-22

[6] Starzl TE(2003)Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era Am J Transplant 3 250-258

[7] Davies SE(2007)Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection Clin Transplant 21 166-171

[8] Portmann BC(2004)Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation Transplant Proc 36 535-538

[9] O’Grady JG(2004)Evolving strategies to prevent HBV recurrence Liver Transplant 10 S74-S85

[10] Aldis PM(2003)A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation J Hepatol 38 811-817

[1] Todo S(1991)Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 619-626

[2] Demetris AJ(1991)Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 150-157

[3] Van Thiel D(1992)Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications J Hepatol 14 104-111

[4] Teperman L(2001)A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation Liver Transplant 7 504-510

[5] Fung JJ(1997)Hepatitis-B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation Lancet 349 20-22

[6] Starzl TE(2003)Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era Am J Transplant 3 250-258

[7] Davies SE(2007)Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection Clin Transplant 21 166-171

[8] Portmann BC(2004)Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation Transplant Proc 36 535-538

[9] O’Grady JG(2004)Evolving strategies to prevent HBV recurrence Liver Transplant 10 S74-S85

[10] Aldis PM(2003)A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation J Hepatol 38 811-817